本文選題：疏肝健脾　切入點(diǎn)：功能性消化不良　出處：《山東中醫(yī)藥大學(xué)》2016年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:系統(tǒng)評(píng)價(jià)疏肝健脾法治療功能性消化不良的臨床療效。方法:通過(guò)計(jì)算機(jī)及手工檢索對(duì)2006年5月—2015年12月期間國(guó)內(nèi)公開(kāi)發(fā)表的,關(guān)于采用疏肝健脾法中醫(yī)藥與西藥對(duì)照治療功能性消化不良的臨床隨機(jī)對(duì)照試驗(yàn)的文獻(xiàn)研究進(jìn)行搜集,并按照納入、排除標(biāo)準(zhǔn)進(jìn)行篩選,選出符合要求的文獻(xiàn)。采用Cochrane協(xié)作網(wǎng)系統(tǒng)評(píng)價(jià)手冊(cè)對(duì)文獻(xiàn)質(zhì)量進(jìn)行評(píng)價(jià),并對(duì)其進(jìn)行Meta分析。結(jié)果:本研究共篩選出25篇符合納入標(biāo)準(zhǔn)的文獻(xiàn),納入研究樣本量共2391例,其中試驗(yàn)組1239人,對(duì)照組1152人。Meta分析結(jié)果:總療效評(píng)價(jià),RR值=1.23,95%CI(1.17,1.30),RR合并假設(shè)檢驗(yàn)Z=7.57,P0.00001,說(shuō)明疏肝健脾法中藥治療功能性消化不良療效優(yōu)于西藥;安全性分析,中藥治療FD的藥物不良反應(yīng)出現(xiàn)率為3.2%,西藥組為15.6%,OR合并假設(shè)檢驗(yàn),Z=3.37(P=0.0008),即中藥組比西藥組在治療FD過(guò)程中安全性更好;復(fù)發(fā)率分析,治療組復(fù)發(fā)率為13.3%,對(duì)照組復(fù)發(fā)率為31.7%,OR合并假設(shè)檢驗(yàn),Z=4.93(P0.00001),即中藥組治療FD的復(fù)發(fā)率比西藥組更低。結(jié)論:疏肝健脾法中藥治療功能性消化不良療效及安全性優(yōu)于西藥,復(fù)發(fā)率較西藥組更低。由于納入文獻(xiàn)的搜索并不完全,且納入文獻(xiàn)的質(zhì)量評(píng)價(jià)較低,結(jié)果的可參考性仍有待商榷,本研究仍存在一定的局限性。
[Abstract]:Objective: to evaluate the clinical efficacy of the method of soothing liver and strengthening spleen in the treatment of functional dyspepsia. The literature on the randomized controlled trial of treating functional dyspepsia with traditional Chinese medicine (TCM) and western medicine (Western medicine) was collected and screened according to the criteria of inclusion and exclusion. The quality of the literature was evaluated by the Cochrane system evaluation manual and analyzed by Meta. Results: 25 articles were selected to meet the inclusion criteria, and 2391 samples were included in the study. Results of Meta-analysis of 1239 patients in the experimental group and 1152 in the control group: the RR value of the total curative effect was 1.2395CI1.171.171.30C / RR combined with hypothesis test ZH7.57 P0.00001, which indicated that the curative effect of traditional Chinese medicine for soothing the liver and strengthening the spleen was better than that of the western medicine, and the safety analysis showed that the traditional Chinese medicine for soothing the liver and strengthening the spleen was superior to the western medicine for treatment of functional dyspepsia. The occurrence rate of adverse drug reactions in the treatment of FD with Chinese medicine was 3.2 and that in the western medicine group was 15.6OR combined with hypothesis test, that is, the safety of TCM group was better than that of western medicine group in the treatment of FD, and the recurrence rate was analyzed. The relapse rate of the treatment group was 13.3g and that of the control group was 31.7or plus hypothesis test. The recurrence rate of FD in the Chinese medicine group was lower than that in the western medicine group. Conclusion: the curative effect and safety of traditional Chinese medicine for the treatment of functional dyspepsia is better than that of western medicine. The recurrence rate was lower than that in the western medicine group. Because the search for the included literature was not complete and the quality evaluation of the included literature was low, the referential value of the results was still open to question, and there were still some limitations in this study.
【學(xué)位授予單位】：山東中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R259

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 徐因;劉莉?qū)?楊志軍;程永波;白瑞雪;賈小紅;;“老十針”合調(diào)神穴治療功能性消化不良臨床觀察[J];遼寧中醫(yī)雜志;2015年12期

2 楊潔;王瑋;;健脾理氣法治療功能性消化不良療效觀察[J];中醫(yī)臨床研究;2015年23期

3 吳小彬;梁超;;疏肝理氣建中法治療功能性消化不良臨床觀察[J];四川中醫(yī);2015年08期

4 曹鄭云;;四君子湯合四逆散加味治療功能性消化不良伴抑郁癥30例總結(jié)[J];湖南中醫(yī)雜志;2014年09期

5 羅穎;張建榮;;疏肝健脾寧心方治療功能性消化不良隨機(jī)平行對(duì)照研究[J];實(shí)用中醫(yī)內(nèi)科雜志;2014年09期

6 楊瑩瑩;;柴胡疏肝散加減聯(lián)合黛力新治療肝郁脾虛型功能性消化不良隨機(jī)平行對(duì)照研究[J];實(shí)用中醫(yī)內(nèi)科雜志;2013年13期

7 何鑌;施琴;高明友;王鶴林;董力;潘軍;曹正龍;;“香蘇和胃丸”治療功能性消化不良110例臨床觀察[J];江蘇中醫(yī)藥;2013年07期

8 雷良蓉;朱海豫;沈瑞芳;;疏肝健脾和胃法治療功能性消化不良(肝胃不和證)的臨床研究[J];中國(guó)實(shí)驗(yàn)方劑學(xué)雜志;2013年11期

9 肖鵬;晏海飛;劉小寶;江平頻;廖朝青;;健脾疏肝調(diào)氣和中法治療功能性消化不良[J];實(shí)用中西醫(yī)結(jié)合臨床;2012年05期

10 何占德;;香砂六君子湯加減治療脾胃氣虛型功能性消化不良療效觀察[J];中醫(yī)藥臨床雜志;2012年09期

，

本文編號(hào)：1618234